Cardiol Therapeutics Inc - Class A (CRDL) Stock Price

1.065 ▲ +0.035 (+3.40%)
Open: 1.055 Vol: 120 Day's range: 1.055 - 1.07 Jun 15, 11:45 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CRDL Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.06▲ 1.05▲ 1.05▲ 1.06▲ 1.15▼
MA10 1.06▲ 1.05▲ 1.05▲ 1.09▼ 1.27▼
MA20 1.05▲ 1.05▲ 1.05▲ 1.18▼ 1.18▼
MA50 1.06▲ 1.06▲ 1.09▼ 1.30▼ 1.13▼
MA100 1.05▲ 1.09▼ 1.16▼ 1.18▼ 1.32▼
MA200 1.06▲ 1.18▼ 1.24▼ 1.11▼ 1.19▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.002▲ 0.002▲ 0.004▲ -0.014▼ -0.027▼
RSI 63.504▲ 56.533▲ 50.970▲ 34.028▼ 44.063▼
STOCH 80.000     51.667     32.937     10.797▼ 20.529    
WILL %R -20.000▲ -16.667▲ -28.571     -87.097▼ -79.375▼
CCI 111.186▲ 110.303▲ 102.610▲ -74.479     -102.354▼
Latest Filters Detected On CRDL
▲ RSI $CRDL RSI(14) Crossed Above 30 Set Alert
▲ GAP $CRDL Open Gap Up %2 Set Alert
CDL $CRDL Harami Candlestick Pattern Detected Set Alert
Cardiol Therapeutics Inc - Class A News
Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ
Wednesday, May 13, 2026 09:27 PM
TORONTO, May 14, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic ...
$30 Billion Per Year US Heart Failure Market Presents Huge Opportunity for Promising Drugs Advancing with Positive Trial Results for Cardiol Therapeutics Inc. (NASDAQ: CRDL ...
Sunday, April 12, 2026 05:00 PM
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. The ...
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
Friday, January 23, 2026 06:16 AM
Toronto, Ontario--(Newsfile Corp. - January 23, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the ...
CRDL historical stock data
date open high low close volume
15/06/26 1.055 1.07 1.055 1.065 102,145
12/06/26 1.07 1.08 1.03 1.03 236,967
11/06/26 1.05 1.07 1.025 1.07 203,976
10/06/26 1.07 1.10 1.035 1.05 373,973
09/06/26 1.08 1.105 1.05 1.08 326,945
08/06/26 1.12 1.14 1.08 1.08 344,230
05/06/26 1.13 1.155 1.10 1.11 422,496
04/06/26 1.11 1.18 1.10 1.15 473,205
03/06/26 1.12 1.145 1.10 1.12 817,381
02/06/26 1.22 1.22 1.15 1.15 409,173
Quote Details
52wk Low:0.88
52wk High:1.71
Vol:120
Avg Vol(3m):9.1M
1Y Chng:-23.38%
1M Chng:-19.92%
Add to Watch List
More Information
Index US Composite
Market Cap. 123.34M